This is an excerpt from a member-only article. To read the article in its entirety, please login or subscribe.

Disciplinary decisions and researcher misconduct at the National Institutes of Health took center stage during a congressional hearing earlier this week, The Baltimore Sun reported. One senior researcher, Thomas J. Walsh, MD, entered into dozens of unauthorized private arrangements with drug companies and failed to report an annual outside income totaling more than $100,000, The Sun reported a confidential internal NIH review as finding.